Optimal Timing for Doxepin in Premature Ejaculation
Doxepin is not recommended for premature ejaculation treatment—you should use dapoxetine 30-60 mg taken 1-3 hours before sexual activity, or daily paroxetine 20 mg if dapoxetine is unavailable.
Critical Clarification
There appears to be confusion in your question. Doxepin is a tricyclic antidepressant not indicated for premature ejaculation. The evidence-based treatments for PE are:
First-Line Pharmacological Options
For on-demand (PRN) therapy:
- Dapoxetine 30 mg taken 1-3 hours before anticipated sexual activity is the only SSRI specifically approved for PE and represents first-line on-demand treatment 1, 2, 3
- This timing (1-3 hours pre-intercourse) allows for optimal plasma concentrations 3
- In men with baseline IELT <30 seconds, dapoxetine 30 mg produces a 3.4-fold increase in ejaculatory latency 2, 3
- If 30 mg proves insufficient, escalate to dapoxetine 60 mg, which provides superior efficacy with a 4.3-fold increase in IELT 1
For daily therapy (most effective approach):
- Daily paroxetine 20 mg provides the strongest ejaculatory delay, increasing IELT by 8.8-fold over baseline 1, 2
- Daily dosing provides more consistent and stronger ejaculatory delay compared to on-demand SSRI use 1, 2
- Start at 10 mg daily and titrate to 20 mg as needed 2
Treatment Selection Algorithm
Choose based on sexual activity frequency:
- Frequent sexual activity (≥2-3 times weekly): Daily paroxetine 20 mg is preferred for maximum efficacy 1, 2
- Infrequent sexual activity: Dapoxetine 30-60 mg on-demand 1-3 hours before intercourse 1, 3
- Patient refuses daily medication: Dapoxetine is the appropriate choice 3
Alternative PRN Strategy with Paroxetine (if dapoxetine unavailable)
If dapoxetine is not available in your country (not FDA-approved in USA):
- Start daily paroxetine 10-20 mg for 14-21 days to achieve steady-state levels 2
- Then switch to PRN dosing of 20 mg taken 3-4 hours before planned sexual activity 2
- Note: This provides substantially less ejaculatory delay than daily treatment 2
Critical Safety Considerations
Contraindications and warnings:
- Do not combine SSRIs with MAOIs due to serotonin syndrome risk 2, 3
- Avoid dapoxetine in patients with bipolar depression (risk of mania) 3
- Monitor patients under age 24 or those with comorbid depression for suicidal ideation 3
- Never abruptly discontinue daily-dosed SSRIs to prevent withdrawal syndrome 2, 3
Common Pitfalls to Avoid
- Using subtherapeutic PRN doses: The evidence-based PRN dose of paroxetine is 20 mg, not 10 mg 2
- Expecting immediate results with daily SSRIs: Requires 14-21 days to reach steady state 2
- Prescribing PDE5 inhibitors alone: These do not significantly improve IELT in men with normal erectile function, though they can be combined with SSRIs for partial responders 1
- Patient discontinuation: 40% refuse or discontinue off-label SSRIs within 12 months; dapoxetine discontinuation reaches 90% at 2 years, mainly due to cost and disappointment 3
Alternative Non-SSRI Options
If SSRIs are contraindicated or ineffective: